Illustrative Core 360 MOTS-c concept packaging

Product images are illustrative. Actual packaging may differ. Images do not indicate FDA approval or treatment eligibility.

Research peptide

MOTS-c

A mitochondrial-derived peptide being investigated for metabolic signaling. It is not an established weight-loss treatment.

What is MOTS-c?

MOTS-c is a short peptide associated with mitochondria, the structures involved in cellular energy production. Researchers are exploring its relationship to metabolism and responses to physical activity.

Why people ask about it

Interest centers on metabolic health, exercise, and body composition. Research findings are not evidence that a MOTS-c product will improve endurance, preserve muscle, or cause weight loss in people.

Evidence & important considerations

MOTS-c is not an FDA-approved drug. Reliable evidence of clinical effectiveness and long-term safety remains limited. For weight-management goals, compare established options and a structured program such as Core Transform with your provider.

Sources & further reading

Information reviewed September 16, 2026.

Keep learning

Explore related guides.

Research peptide

Semax

A synthetic peptide studied in neurological research. Cognitive and focus benefits remain unestablished.

Learn about Semax

Research peptide

BPC-157

An experimental peptide studied in tissue and gastrointestinal research. Human benefits and safety are not established.

Learn about BPC-157

Paris & Camden, Tennessee

Start feeling like
yourself again.

Your health is personal. Your treatment should be too.

Let’s talk about your goals
Call CoreBook an appointment ↗